Moderna on Friday unveiled its strategy for addressing the new COVID-19 variant B.1.1.529 known as Omicron, joining competitors Pfizer and Johnson & Johnson, who detailed plans of their own the same day.
The new Omicron variant was discovered in South Africa,…
